4D Molecular Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
36.00
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.91
|
-0.79
|
0.12
|
13.19%
|
|
2022-06-30
|
-0.85
|
-0.87
|
-0.02
|
-2.35%
|
|
2022-03-31
|
-0.81
|
-0.82
|
-0.01
|
-1.23%
|
|
2021-12-31
|
-0.86
|
-0.85
|
0.01
|
1.16%
|
|
2021-09-30
|
-0.80
|
-0.82
|
-0.02
|
-2.50%
|
|
2021-06-30
|
-0.68
|
-0.28
|
0.40
|
58.82%
|
|
2021-03-31
|
-1.10
|
-0.61
|
0.49
|
44.55%
|
|
2020-12-31
|
-0.66
|
-2.36
|
-1.70
|
-257.58%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.48
|
|
2021-12-31
|
-2.56
|
|
2020-12-31
|
-11.98
|
|
2018-12-31
|
-2.98
|
|
2017-12-31
|
-0.52
|